Immortalized Human Hepatocytes-HPV

Cat.No.: CSC-I9339L

Species: Homo sapiens

Source: Liver

Culture Properties: Adherent

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-I9339L
Description
Human hepatocytes plays an important role in life science research for evaluation of key human-specific drug properties, such as of drugs interactions, toxicity tests and metabolism reactions. Since primary cells are often hard to propagate in culture.Creative Bioarray offers immortalized human hepatocytes that allows the cells to escape senescence crisis and help further research needs by extending the passage ability that primary cells lacks. These cells are ready-to-use for applications in research and developmental viral infections, screening, co-cultures and transfections.
Species
Homo sapiens
Source
Liver
Culture Properties
Adherent
Immortalization Method
Serial passaging and transduction with lentiviruses carrying Human papillomavirus E6/E7 protein
Application
For Research Use Only
Storage
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.

Note: Never can cells be kept at -20 °C.
Shipping
Dry Ice.
Recommended Products
CSC-C1495 Human Hepatocytes
CIK-HT018 HT® Lenti-HPV-16 E6/E7 Immortalization Kit
Quality Control
Real Time PCR was used to quantify HPV E6/E7 gene expression in immortalized cell line.
BioSafety Level
II
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

The Immortalized Human Hepatocyte (IHH) cell line, established through the stable integration of Human Papillomavirus (HPV) E6 and E7 oncogenes, represents a pivotal advancement in liver-centric biotechnology. By neutralizing the p53 and pRb tumor suppressor pathways, this model bypasses the stringent Hayflick limit of primary human hepatocytes (PHHs), enabling sustained longitudinal studies without the loss of lineage-specific functionality.

  • Preserved Metabolic Competence: Unlike traditional hepatoma-derived lines (e.g., HepG2 or Huh7) that exhibit significant metabolic derangement, HPV-immortalized hepatocytes maintain a high degree of differentiated function. They express critical Phase I and II drug-metabolizing enzymes, including key Cytochrome P450 (CYP) isoforms, facilitating more predictive toxicology and pharmacology assays.
  • Superior Scalability & Reproducibility: These cells offer an inexhaustible supply for high-throughput screening (HTS). This eliminates the inter-donor variability inherent in PHH lots, providing researchers with a standardized, cost-effective baseline for global longitudinal data comparison.
  • Enhanced Viral Susceptibility: The E6/E7-mediated immortalization maintains the expression of essential viral entry receptors (such as NTCP), rendering these cells an excellent substrate for studying Hepatitis B and C (HBV/HCV) replication kinetics and antiviral drug efficacy.
  • Functional Synthetic Capacity: Our IHH-HPV line continues to synthesize and secrete essential plasma proteins, such as albumin and transferrin, and retains the ability for urea cycle activity, making it a robust model for metabolic disease research, including NAFLD and NASH.

Designed for the rigorous demands of pharmaceutical R&D, these cells serve as a high-fidelity surrogate for in vivo liver tissue. By offering a stable, biologically relevant, and "assay-ready" human cell system, the Immortalized Human Hepatocytes-HPV minimize the translational gap between in vitro discovery and clinical application, significantly accelerating the pipeline for novel hepatology therapeutics.

Cellular Senescence in Hepatocytes Contributes to Metabolic Disturbances in NASH

Cellular senescence is a state of irreversible cell cycle arrest and has been shown to play a key role in many diseases, including metabolic diseases. To investigate the potential contribution of hepatocyte cellular senescence to the metabolic derangements associated with non-alcoholic steatohepatitis (NASH), we treated human hepatocyte cell lines HepG2 and IHH with the senescence-inducing drugs nutlin-3a, doxorubicin and etoposide.

In order to determine whether cellular senescence affects hepatic lipid accumulation, lipid content was measured in senescent and control hepatocytes, in the absence or in the presence of oleic acid (OA) for 24h, in order to mimic pro-steatotic conditions. Hepatocytes treated with Nut, Eto and Doxo for 5 days displayed an increase in Oil Red O staining compared to control cells. In conditions with OA, the increased accumulation of lipids in senescent cells was even more pronounced (Fig. 1A, B, D, E). Quantification of intracellular triglycerides (TG) confirmed the increase in lipid content in senescent cells (Fig. 1C-F).

Next, we wanted to investigate the effect of cellular senescence on glucose metabolism. The results show that senescence causes changes in glucose metabolism in hepatocytes, including increased glycogen content (Fig. 2A), increased hepatic glucose output (Fig. 2C), as well as increased glucose oxidation capacity (Fig. 2D).

Together, these data indicate that hepatic senescence plays a causal role in the development of NASH pathogenesis, by modulating glucose and lipid metabolism, favoring steatosis.

Cellular senescence increases steatosis in human hepatocytes HepG2 and IHH.

Fig. 1. Increased steatosis in senescent human hepatocytes (Bonnet, Laurianne, et al., 2022). Human hepatocytes were treated with nutlin (Nut; 3 µM), etoposide (Eto; 20 µM) and doxorubicin (Doxo; 0,2 µM) for 5 days, with or without the addition of oleic acid (OA) for another 24h. Oil Red O (ORO) staining (A, D), ORO quantification (B, E) and triglyceride (TG) content (C, F) in IHH and HepG2 hepatocytes.

Senescence increases glycogen content, glucose production and glucose oxidation in immortalized human hepatocytes (IHH).

Fig. 2. Increased glycogen content, glucose oxidation and hepatic glucose production in senescent human hepatocytes IHH (Bonnet, Laurianne, et al., 2022).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products